down arrow

Nanjing Vazyme Biotech Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004ZK3
CNY
20.15
0.13 (0.65%)

Dec 19

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Nanjing Vazyme Biotech Co., Ltd.
Why is Nanjing Vazyme Biotech Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 14.45%
  • The company has been able to generate a Return on Capital Employed (avg) of 14.45% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -20.55% and Operating profit at -152.79% over the last 5 years
3
Negative results in Mar 25
  • OPERATING CASH FLOW(Y) Lowest at CNY 76.94 MM
  • INTEREST(Q) At CNY 6.99 MM has Grown at 86.04%
  • NET PROFIT(Q) At CNY -16.46 MM has Fallen at -44.6%
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -14.84%, its profits have fallen by -349.4%
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -14.84% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nanjing Vazyme Biotech Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nanjing Vazyme Biotech Co., Ltd.
-14.51%
-0.21
33.21%
China Shanghai Composite
15.44%
1.01
14.52%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-20.55%
EBIT Growth (5y)
-152.79%
EBIT to Interest (avg)
26.48
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0.34
Tax Ratio
62.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.45%
ROE (avg)
4.52%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.94
EV to EBIT
-12.27
EV to EBITDA
23.35
EV to Capital Employed
0.88
EV to Sales
1.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.17%
ROE (Latest)
-2.37%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -10.54% (YoY

-19What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 76.94 MM

INTEREST(Q)

At CNY 6.99 MM has Grown at 86.04%

NET PROFIT(Q)

At CNY -16.46 MM has Fallen at -44.6%

NET SALES(Q)

Lowest at CNY 284.65 MM

OPERATING PROFIT(Q)

Lowest at CNY -30.66 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -10.77 %

Here's what is working for Nanjing Vazyme Biotech Co., Ltd.
Raw Material Cost
Fallen by -10.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Vazyme Biotech Co., Ltd.
Operating Cash Flow
Lowest at CNY 76.94 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest
At CNY 6.99 MM has Grown at 86.04%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit
At CNY -16.46 MM has Fallen at -44.6%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales
Lowest at CNY 284.65 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit
Lowest at CNY -30.66 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at -10.77 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."